SneakPeek research roundup

U.S. Patent No. 11,932,907:

Fetal Sex Determination Using Capillary Blood From Upper Arm

Coverage:

The patent technology improves the accuracy of a fetal sex test by reducing contaminating DNA in maternal blood samples.

Population:

1,029 women between 7-37 weeks of gestational age

Stats:

1,028 of 1,029 SneakPeek test results matched the baby’s gender at birth, making SneakPeek Gender 99.9% accurate.

Outcome:

This is the largest clinical study of its kind and the only one that compares test results with sex at birth.

Population:

115 pregnant women

Stats:

Gender samples taken at 6, 7, and 8-10 weeks into pregnancy matched at every time point.

Outcome:

Fetal sex was accurate for all 115 women – (100% accurate) in this study at 6 weeks into pregnancy.

Population:

151 pregnant women with average gestational age of 9.6 weeks who took SneakPeek Gender using both Snap and Lancet

Stats:

• 90% found Snap to be completely painless, versus 22% for Lancet.
• 90% found Snap to be easy to use, versus 40% for Lancet.
• 0% of Snap samples had male DNA contamination.

Outcome:

Snap vastly outperforms Lancet in pain level, ease of use, and reducing test-taking errors.